Connection

Jean-Charles Soria to Administration, Oral

Back to Details
This is a "connection" page, showing publications Jean-Charles Soria has written about Administration, Oral.
Jean-Charles Soria
Connection Strength
0.026
Administration, Oral
  1. Phase I open-label study of afatinib plus vinorelbine in patients with solid tumours overexpressing EGFR and/or HER2. Br J Cancer. 2018 02 06; 118(3):344-352.
    View in: PubMed
    Score: 0.026
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.